cabozantinib,avelumab,atezolizumab
exelixis,roche,merck,Pfizer
['main-cav', 'cosmic021', 'atlantis', 'urothelial']
stellar discussion by on atlantis maintenance trial by dr. rob jones &amp; cosmic021 by the role of anti-vegf remains questionable, not adding much to io in advanced urothelial ca, but main-cav is pending #asco22 
Oncologist, Associate Prof, clinical/translational research, Genitourinary Cancers, bladder, prostate, testis, Univ of Washington, Fred Hutch, SCCA; views mine